18F-FEPPA

N/A

Report date: 2025/11/21 17:15:17
NME

Base Information

Drug Name18F-FEPPA
Drug Alias Name18F-FEPPA[18F]FE-PBR28[18F] FEPPA
ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F +[5] 
Mechanisms of ActionTranslocator protein ligandsTranslocator protein modulators
TargetsTranslocator protein
Therapy Area/IndicationsFrontotemporal DementiaAlzheimer DiseaseParkinson Disease +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Toronto - St. George Campus
China Registration ClassN/A

Develop Information

Active CompaniesNational Heart, Lung, And Blood Institute (Nhlbi)
Inactive CompaniesLawson Health Research InstituteThe Institute For Neurodegenerative Disorders Inc
Active IndicationsAsthma
Inactive IndicationsFrontotemporal DementiaAlzheimer DiseaseParkinson Disease +[4] 

Other Information

ATC CodeN/A
Related LinksN/A